07-05-2012: Population Genetics Technologies Ltd. has appointed Alan Schafer, PhD to the post of Chief Executive Officer.
Schafer brings deep experience in research, “big pharma” management and building new businesses. He is Adjunct Professor of Innovation at Imperial College London Business School and was previously the Wellcome Trust’s Director of Science Funding. Before that he served as Global Vice-President of Technology Development at GlaxoSmithKline and co-founded Hexagen, a functional genomics company and subsequently acquired by Incyte. He will continue to serve on a number of research and venture capital advisory boards.
Contact / Request information
Request further information free of charge:
Alan Schafer to head Population Genetics
Population Genetics Technologies Ltd. has appointed Alan Schafer, PhD to the post of Chief Executive Officer. Schafer brings deep experience in research, “big pharma” management and building new businesses. He is Adjunct Professor of Innovation at Imperial College London Business School and ... more
Mass Analysis of DNA from Whole Populations
Nobel Prize winner Dr Sydney Brenner has devised a new method for obtaining sequence information from thousands of genomes simultaneously. Current technologies can only analyse one genome at a time. This method, to be developed by a new company called Population Genetics Technologies, is ex ... more
Über analytica-world.com
'analytica-world.com is the industry portal of the international trade fair analytica, which is organized by Messe München. It features useful information about markets, trends and innovations. It is operated by CHEMIE.DE, one of analytica''s official sales partners.'
Advertising at analytica-world.com
Our advertising formats support you in getting your message across to a clearly defined target audience.
The global network of analytica trade fairs:
